Internal Medicine, Hematology & Oncology · Encinitas, CA
NPI
1053519280
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1200 Garden View Rd, Suite 200
Encinitas, CA, 92024
Phone (760) 536-7700
Groups this clinician bills Medicare through
Medicare paid, 2024
$723K
48,050 services
Medicare patients, 2024
373
Average age 75
Drug cost, 2024
$999K
427 prescriptions
Company payments, 2023
$56.53
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anjali A Bharne was code J1439 (injection, ferric carboxymaltose, 1 mg), 17,200 times for 13 patients. In total Anjali A Bharne billed 48,050 services in 88 codes, and Medicare paid $723K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 17,200 | 13 | $0.87 | $15K |
| J0897 Injection, denosumab, 1 mg | Office | 2,460 | 13 | $20.86 | $51K |
| 99215 Office E&M - Established | Office | 322 | 107 | $134.37 | $43K |
| 99214 Office E&M - Established | Office | 315 | 159 | $90.81 | $29K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 262 | 11 | $0.09 | $24.01 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 249 | 60 | $0.51 | $128 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 216 | 68 | $13.07 | $2,824 |
| 96523 Chemotherapy | Office | 120 | 40 | $22.58 | $2,709 |
| 96372 Injection Administration | Office | 102 | 41 | $12.47 | $1,272 |
| 96375 Injection Administration | Office | 97 | 19 | $13.65 | $1,324 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 92 | 20 | $2.07 | $191 |
| 96360 Intravenous Infusion, Hydration | Office | 86 | 18 | $29.21 | $2,512 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 83 | 15 | $4.55 | $377 |
| 96365 Intravenous Infusion, Hydration | Office | 76 | 41 | $55.29 | $4,202 |
| J7060 5% dextrose/water (500 ml = 1 unit) | Office | 75 | 19 | $1.43 | $107 |
By year: 2022 $375K for 37,704 services; 2023 $674K for 48,924 services; 2024 $723K for 48,050 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 24 | 13 | $7.61 | $183 |
Medicare prescription drug claims, 2024
In 2024, the drug Anjali A Bharne prescribed most often to Medicare patients was Hydroxyurea, with 42 prescriptions and refills. In total Anjali A Bharne wrote 427 Medicare prescriptions that cost $999K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 42 | 90 | Under 11 | $609 |
| Lorazepam Generic | 25 | 30 | Under 11 | $93.63 |
| Xarelto Rivaroxaban | 21 | 31 | Under 11 | $17K |
| Revlimid Lenalidomide | 16 | 16 | Under 11 | $377K |
| Gabapentin Generic | 15 | 19 | Under 11 | $283 |
| Exemestane Generic | 14 | 24 | Under 11 | $1,325 |
| Imbruvica Ibrutinib | 14 | 14 | Under 11 | $196K |
| Prochlorperazine Maleate Generic | 14 | 14 | 11 | $151 |
| Tramadol Hcl Generic | 13 | 13 | Under 11 | $82.52 |
| Eliquis Apixaban | 12 | 19 | Under 11 | $10K |
| Zolpidem Tartrate Generic | 12 | 12 | Under 11 | $17.5 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 11 | 11 | Under 11 | $98.04 |
| Bicalutamide Generic | 11 | 15 | Under 11 | $258 |
| Aromasin Exemestane | 11 | 11 | Under 11 | $13K |
Brand drugs: - claims; generic drugs: 303 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Anjali A Bharne $56.53 ($56.53 in general payments such as food, travel and fees) from 2 companies. The largest payer was Aveo Pharmaceuticals, Inc. with $35.53.
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 2 | $35.53 |
| Mirati Therapeutics, Inc. BMY | 1 | $21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.